Allen P, Smith A, Benedicto V, Abdulhassan A, Narayanaswami V, Tapavicza E
ArXiv. 2023; .
PMID: 37645042
PMC: 10462174.
Costagliola di Polidoro A, Cafarchio A, Vecchione D, Donato P, De Nola F, Torino E
Molecules. 2022; 27(19).
PMID: 36235232
PMC: 9572160.
DOI: 10.3390/molecules27196696.
Hirose S, Hioki Y, Miyashita H, Hirade N, Yoshitake J, Shibata T
J Biol Chem. 2019; 294(28):11035-11045.
PMID: 31167785
PMC: 6635438.
DOI: 10.1074/jbc.RA118.006629.
He P, Tian N
Korean J Physiol Pharmacol. 2019; 23(3):181-189.
PMID: 31080349
PMC: 6488708.
DOI: 10.4196/kjpp.2019.23.3.181.
Daminelli E, Fotakis P, Mesquita C, Maranhao R, Zannis V
Lipids. 2017; 52(12):991-998.
PMID: 29094255
DOI: 10.1007/s11745-017-4306-6.
Early Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle Cells.
Damian-Zamacona S, Toledo-Ibelles P, Ibarra-Abundis M, Uribe-Figueroa L, Hernandez-Lemus E, Macedo-Alcibia K
PLoS One. 2016; 11(10):e0163924.
PMID: 27727291
PMC: 5058556.
DOI: 10.1371/journal.pone.0163924.
Particulate matter promotes in vitro receptor-recognizable low-density lipoprotein oxidation and dysfunction of lipid receptors.
Manzano-Leon N, Mas-Oliva J, Sevilla-Tapia L, Morales-Barcenas R, Serrano J, O Neill M
J Biochem Mol Toxicol. 2013; 27(1):69-76.
PMID: 23297186
PMC: 4345123.
DOI: 10.1002/jbt.21452.
Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men.
Faghihnia N, Mangravite L, Chiu S, Bergeron N, Krauss R
Eur J Clin Nutr. 2012; 66(11):1229-33.
PMID: 22948944
PMC: 3491165.
DOI: 10.1038/ejcn.2012.118.
Apolipoprotein E: from lipid transport to neurobiology.
Hauser P, Narayanaswami V, Ryan R
Prog Lipid Res. 2010; 50(1):62-74.
PMID: 20854843
PMC: 3022415.
DOI: 10.1016/j.plipres.2010.09.001.
Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid.
Khumsupan P, Ramirez R, Khumsupan D, Narayanaswami V
Biochim Biophys Acta. 2010; 1808(1):352-9.
PMID: 20851099
PMC: 2997894.
DOI: 10.1016/j.bbamem.2010.09.007.
Hypermutation induced by APOBEC-1 overexpression can be eliminated.
Chen Z, Eggerman T, Bocharov A, Baranova I, Vishnyakova T, Csako G
RNA. 2010; 16(5):1040-52.
PMID: 20348446
PMC: 2856876.
DOI: 10.1261/rna.1863010.
Structure of the minimal interface between ApoE and LRP.
Guttman M, Prieto J, Handel T, Domaille P, Komives E
J Mol Biol. 2010; 398(2):306-19.
PMID: 20303980
PMC: 2880916.
DOI: 10.1016/j.jmb.2010.03.022.
Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E.
Guttman M, Prieto J, Croy J, Komives E
Biochemistry. 2009; 49(6):1207-16.
PMID: 20030366
PMC: 2821871.
DOI: 10.1021/bi9017208.
An optimized negative-staining protocol of electron microscopy for apoE4 POPC lipoprotein.
Zhang L, Song J, Newhouse Y, Zhang S, Weisgraber K, Ren G
J Lipid Res. 2009; 51(5):1228-36.
PMID: 19965615
PMC: 2853450.
DOI: 10.1194/jlr.D002493.
Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.
Jones C, Garuti R, Michaely P, Li W, Maeda N, Cohen J
J Clin Invest. 2007; 117(1):165-74.
PMID: 17200716
PMC: 1716209.
DOI: 10.1172/JCI29415.
Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M, Patarroyo-White S, Qian X, Arnold K, Rohrer L, Balestra M
Biochem J. 2002; 369(Pt 2):255-62.
PMID: 12374571
PMC: 1223090.
DOI: 10.1042/BJ20020694.
Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes.
Versluis A, Rensen P, Rump E, Van Berkel T, Bijsterbosch M
Br J Cancer. 1998; 78(12):1607-14.
PMID: 9862571
PMC: 2063239.
DOI: 10.1038/bjc.1998.730.
Synthesis of a lipophilic daunorubicin derivative and its incorporation into lipidic carriers developed for LDL receptor-mediated tumor therapy.
Versluis A, Rump E, Rensen P, Van Berkel T, Bijsterbosch M
Pharm Res. 1998; 15(4):531-7.
PMID: 9587947
DOI: 10.1023/a:1011917508056.
An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo.
Nikoulin I, Curtiss L
J Clin Invest. 1998; 101(1):223-34.
PMID: 9421485
PMC: 508559.
DOI: 10.1172/JCI1099.
Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells.
Voyno-Yasenetskaya T, Dobbs L, Erickson S, Hamilton R
Proc Natl Acad Sci U S A. 1993; 90(9):4256-60.
PMID: 8483941
PMC: 46485.
DOI: 10.1073/pnas.90.9.4256.
